http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1976850-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99505f5f312672820e9f78c254c00a4d |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-103 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-532 |
filingDate | 2007-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94a71e97450da564c275484b6a2f7cf0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c67adefaa145574da64a9d52129a5c71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9656843cf39ef979440327c126d2d43 |
publicationDate | 2008-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1976850-A1 |
titleOfInvention | Novel lanthanide ligands and complexes, and use thereof as contrast agents |
abstract | The present invention relates to a ligand for metals, in particular lanthanides, of general formula (I) in which A corresponds to an organic acid radical, or to an alkyl ester or an aryl ester, R1 and R2 correspond, individually and independently of one another, to an H, to an alkyl radical or to an aryl radical, Z1 and Z2, which may be identical or different, are of general formula (ZA) OR (ZB), in which: G represents an O, N, P, S or a C, independently substituted with an H, an alkyl radical or an aryl radical, and R3 to R8 correspond, individually and independently of one another, to an H, to an alkyl radical or to an aryl radical. The present invention also relates to coordination complexes of general formula in which: Ln is a lanthanide, L corresponds to a ligand, and also to the grafting thereof to a molecule of interest and to the process for the preparation thereof. The present invention also relates to a contrast agent and to a pharmaceutical composition containing at least one ligand and/or complex and/or molecule of interest. |
priorityDate | 2006-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.